4baseCare Now Offers Its Services in Dubai

Nitin Konde, Varun Bhardwaj

Oct 26, 2024 — 2 min read

4baseCare Now Offers Its Services in Dubai

In partnership with Innovate Life Sciences, 4baseCare has opened a genomics lab at Dubai Science Park to begin operations in the city. 4baseCare's strategy plan to increase its presence in Southeast Asia and the Middle East aligns with this expansion. This growth has been fuelled in large part by the recent $6 million fund raise from Yali Capital, which has also opened the door for future expansion into other international regions.

Whole exome sequencing, transcriptome analysis, and comprehensive cancer gene panels are among the genomic testing services offered by the new genomics lab. By delving deeper into the genetic composition of tumours, oncologists will be able to provide more individualised and potent treatment options thanks to these cutting-edge techniques.

According to Marwan Abdulaziz Janahi, Senior Vice President of Dubai Science Park at TECOM Group, 4baseCare's collaboration with Innovate Life Sciences, one of more than 500 industry leaders at Dubai Science Park, is a crucial step in maximising the potential of genomics, which is necessary to unlock life-changing therapies.

"In keeping with the objectives of the Dubai Research and Development Programme and the Dubai Economic Agenda "D33," the community of Dubai Science Park is facilitating healthcare innovations for the benefit of patients through partnerships like Innovate Life Sciences and 4baseCare," Janahi stated further.

Partnership is Marked as a Game-Changer in Dubai’s Healthcare Domain

"Cancer affects everyone, including our communities, neighbours, and families," according to Hitesh Goswami, CEO of 4baseCare. "We must take action immediately because the disease's worldwide burden is only increasing. We are giving cancer sufferers in the Middle East hope through this collaboration." "We are committed to ensuring that advanced, personalised cancer care is within reach for everyone who needs it," Goswami stated.

"We are working together to control the financial burden of cancer and increase access to cancer care through our new cooperation at Dubai Science Park. Unquestionably, one of the ME region's challenges is the growing expense of cancer control. The cooperation of multiple stakeholders will be necessary for the long-term viability of oncology care. We are totally dedicated to assisting physicians and patients in the Middle East in utilising the greatest precision oncology has to offer through this collaboration," he continued.

Additionally, 4baseCare introduced SoLiq, a collection of solid-liquid NGS assays that gives oncologists a comprehensive understanding of tumour biology by fusing the greatest features of liquid and solid biopsy technologies.

About 4baseCare

Using advanced genomics and next-generation digital health technology, 4baseCare, a Singapore-based company with Illumina backing, is creating innovative precision oncology solutions. It has created a special collection of in-house comprehensive cancer gene panels that allow physicians to select the best precision treatments for their patients, taking into account that clinical outcomes may range greatly throughout communities.